Nunzia Pharmaceutical NUNZ Stock
Nunzia Pharmaceutical Price Chart
Nunzia Pharmaceutical NUNZ Financial and Trading Overview
| Nunzia Pharmaceutical stock price | 0.0030 USD |
| Previous Close | 0.05 USD |
| Open | 0.04 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.01 - 0.04 USD |
| 52 Week Range | 0.01 - 0.7 USD |
| Volume | 29.13K USD |
| Avg. Volume | 1.93K USD |
| Market Cap | 10.86M USD |
| Beta (5Y Monthly) | -1.992605 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NUNZ Valuation Measures
| Enterprise Value | 19.7M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Nunzia Pharmaceutical Stock Price History
| Beta (5Y Monthly) | -1.992605 |
| 52-Week Change | -96.42% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.7 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.05 USD |
| 200-Day Moving Average | 0.22 USD |
NUNZ Share Statistics
| Avg. Volume (3 month) | 1.93K USD |
| Avg. Daily Volume (10-Days) | 3.02K USD |
| Shares Outstanding | 434.52M |
| Float | 78.36M |
| Short Ratio | N/A |
| % Held by Insiders | 81.95% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -270239.14% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -96985616 USD |
| Diluted EPS (ttm) | -0.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 35.37K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 183.35K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.156 |
| Book Value Per Share (mrq) | 0 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -202004 USD |
| Levered Free Cash Flow (ttm) | 36.09M USD |
Profile of Nunzia Pharmaceutical
| Country | United States |
| State | CA |
| City | Long Beach |
| Address | 1627 West 14th Street |
| ZIP | 90813 |
| Phone | 714 609 9117 |
| Website | https://www.nunziapharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
Q&A For Nunzia Pharmaceutical Stock
What is a current NUNZ stock price?
Nunzia Pharmaceutical NUNZ stock price today per share is 0.0030 USD.
How to purchase Nunzia Pharmaceutical stock?
You can buy NUNZ shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nunzia Pharmaceutical?
The stock symbol or ticker of Nunzia Pharmaceutical is NUNZ.
Which industry does the Nunzia Pharmaceutical company belong to?
The Nunzia Pharmaceutical industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nunzia Pharmaceutical have in circulation?
The max supply of Nunzia Pharmaceutical shares is 434.52M.
What is Nunzia Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Nunzia Pharmaceutical PE Ratio is now.
What was Nunzia Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Nunzia Pharmaceutical EPS is -0.3 USD over the trailing 12 months.
Which sector does the Nunzia Pharmaceutical company belong to?
The Nunzia Pharmaceutical sector is Healthcare.